Clinical Trials Directory

Trials / Sponsors / Moleculin Biotech, Inc.

Moleculin Biotech, Inc.

Industry · 7 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingL-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induct
Acute Myeloid Leukaemia (AML)
Phase 2 / Phase 32025-03-12
CompletedStudy of Liposomal Annamycin in Combination With Cytarabine for the Treatment of Subjects With Acute Myeloid L
Leukemia, Myeloid, Acute
Phase 1 / Phase 22022-09-29
CompletedStudy to Assess the Safety and Pharmacokinetics of WP1122 in Healthy Volunteers
Healthy Volunteer
Phase 12022-05-11
CompletedStudy of Liposomal Annamycin for the Treatment of Subjects with Soft-Tissue Sarcomas (STS) with Pulmonary Meta
Sarcoma,Soft Tissue, Pulmonary Metastasis
Phase 1 / Phase 22021-06-05
CompletedStudy of WP1220 for the Treatment of Adult Subjects With Cutaneous T-Cell Lymphoma (CTCL)
Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Phase 12019-03-08
CompletedStudy of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML)
Leukemia, Myeloid, Acute
Phase 1 / Phase 22018-12-17
CompletedStudy of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML)
Leukemia, Myeloid, Acute
Phase 1 / Phase 22018-03-28